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Material/Methods:
Background: Minimal hepatic encephalopathy (MHE) is the mildest form of hepatic encephalopathy (HE). For diagnostic pur-
poses, 2 alternative batteries of psychometric screening tests are recommended. They differ from each other 
in terms of the cognitive domains assessed. The research was designed to provide a profile of cognitive func- 
tioning in patients with liver cirrhosis, using an assessment that covers a wider range of cognitive functions 
than the usual screening battery.
We examined 138 persons, including 88 with liver cirrhosis and 50 healthy volunteers. The Mini Mental State 
Examination (MMSE) was used for screening and excluding advanced cognitive impairment. Then, to assess 
cognitive functions in more detail, the following tests were used: Auditory Verbal Learning Test (AVLT), Letter 
and Semantic Fluency Tests (LF and SF), Trail Making Test (TMT A&B), Digit Symbol Test (DST), Błock Design Test 
(BDT), and MentalRotation Test (MRT). The MRT task has not been used in MHE diagnosis so far. Finally, 57 pa­
tients and 48 controls took part in the entire study.
Results: Patients with liver cirrhosis commit significantly more errors of intrusions in the AVLT during the delayed free re-
call trial. Results significantly deviating from the norm in at least 2 tests were found only in 7 cirrhosis patients.
Conclusions: The results do not provide any specific profile of cognitive disturbances in MHE, but suggest that cirrhosis
patients have a tendency to commit more memory errors, probably due to subtle impairments of executive 
function.
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Background
Minimal hepatic encephalopathy (MHE) is the mildest form of 
overt hepatic encephalopathy (HE). Its occurrence is estimat- 
ed at 30-84%  according to different authors and it strongly 
depends on the diagnostic methods used, as well as the con- 
sidered population [1-4]. The occurrence of MHE in the Polish 
population was estimated by Habior et al to be 17.6-31.3% 
[5]. MHE is a subtle cognitive impairment that can be detected 
with a neuropsychological assessment [6 7]. Other techniques 
using neurophysiological or neuroimaging methods can reveal 
differences in group comparisons; however, individual diagno- 
sis on their basis is currently not possible [8-12]. MHE affects 
quality of life, as well as specific abilities like driving (it increas- 
es the risk of road accidents) [13,14], and can also lead to the 
development of overt hepatic encephalopathy, which is linked 
with increased mortality [3,4,15,16]. A study by Hilsabeck et al 
showed that cognitive disorders can be observed in patients 
with viral hepatitis C, even when no cirrhosis symptoms are 
observed. Intensification of cognitive deficits is related to ad- 
vancement of the liver fibrosis process [17]. From the clinical 
point of view, it is essential to diagnose MHE as soon as possi­
ble in individual cases. This provides an opportunity for imme- 
diate commencement of treatment, which, according to numer- 
ous studies, significantly improves the prognosis [1,4,18,19].
However, the diagnosis of MHE is difficult, as there are no 
clear clinical symptoms that can be easily observed during a 
medical examination. Hence, there are attempts to employ a 
cognitive assessment in a more detailed way than provided 
by the Mini Mental State Examination (MMSE) scale. On the 
other hand, a sufficiently easy method would be preferred in 
order to avoid having to perform a time consuming and less 
available neuropsychological examination [6,7].
Currently, use of a Psychom etric Hepatic Encephalopathy 
Score (PHES) is recommended. This consists of 4 paper-pencil 
tests: Digit Symbol Test (DST), Line Drawing Test (LDT), Serial 
Dotting Test (SDT), and Trail Making Test (TMT; comprised of 
parts A and B, but in the MHE literature sometimes referred 
to as 2 separate number connection tests, which is incorrect) 
[6,7]. All these tests are performed under time pressure. They 
require copying of simple graphic symbols or drawing lines 
from one place to another, or within a defined drawing path. 
Apart from the TMT, which is a commonly used neuropsycho- 
logical test, the rest are not widely used in neuropsychologi- 
cal assessment. It is not clear which detailed aspects of cog- 
nitive functioning they measure besides psychomotor speed, 
which depends on attentional, motor, and perceptual efficien- 
cy. Moreover, all the information from the individual perfor­
mance scores is obscured when the single total PHES score 
is calculated. The sensitivity of PHES is also mediated by age 
and education level [20].
On the other hand, the Commission on Neuropsychological 
Assessment of Hepatic Encephalopathy of the International 
Society for Hepatic Encephalopathy and Nitrogen Metabolism 
(ISHEN) recommends using a battery other than PHES, the 
Repeatable Battery for the Assessment of Neuropsychological 
Status (RBANS) [21]. It is a simplified routine of neuropsycho­
logical assessment, which allows for separate examination of 
the following cognitive domains: immediate memory, visuo-spa- 
tial and construction abilities, attention, language, and delayed 
memory. Among other things, RBANS tasks require figure copy­
ing, learning a list of words and later recall of figure and words, 
picture naming, and choice of correct line orientation that match- 
es the target line. Contrary to the PHES, which is used only in 
MHE research, the RBANS can also be used in screening for ei- 
ther dementia or cognitive impairments in other diseases [22,23].
These 2 methods differ in terms of the range of the examined 
cognitive functions. The PHES score depends to a greater ex- 
tent on psychomotor speed. The RBANS score, on the other 
hand, depends on efficiency in other domains. However, al- 
though RBANS assesses a wider range of abilities, it does not 
allow for measuring executive functions, but the PHES includes 
the TMT test, which does measure them. Hence, the 2 meth­
ods can detect a decrease in cognitive functioning in differ­
ent groups of patients, which in consequence leads to incon- 
sistent MHE diagnosis.
In the present study, a different way of assessing cognitive func­
tions in patients with liver cirrhosis was used. It was expected 
that this would enable quantification of the abilities that are 
also covered by either PHES or RBANS. In addition to typical 
scores defined on the basis of performance time or number of 
correct responses, the number of errors was also considered. 
In typical neuropsychological assessment, when cognitive im­
pairments are suspected it is of key importance to examine the 
number and type of errors committed, instead of global per­
formance. However, this information is rarely taken into ac- 
count during the examination of patients with liver cirrhosis. 
The aim of the study was to determine a profile of cognitive 
functioning in patients with liver cirrhosis and to determine 
the usability of typical clinical tests in the diagnosis of MHE.
Material and Methods
We examined138 subjects, including 88 patients with liver cir­
rhosis being treated in the outpatient clinic of the Department 
of Gastroenterology, Hepatology and Infectious Diseases, 
Jagiellonian University Medical College Hospital and 50 healthy 
volunteers, matched according to demographic data. All partici- 
pants signed written informed consent forms after receiving de­
tailed information regarding the study. The procedure was com- 
pliant with the directives of the Helsinki Declaration (1975; 6th
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revision, 2008) and was approved by the Bioethics Committee 
of Jagiellonian University (approval no. K/PBW/000340).
Criteria used for exclusion were: neurological, psychiatrie or 
other serious diseases unrelated to hepatic insufficiency; any 
symptoms of brain lesions or peripheral nervous system disor- 
ders found during the neurological examination; regular intake 
of anticonvulsants, psychoactive drugs or narcotics reported 
during the inquiry; and symptoms of overt hepatic encepha­
lopathy, stage 1 or more in West Haven criteria and score on 
the MMSE [24] of less than 27. Finally, 57 patients and 48 con- 
trols took part in the entire study.
Liver cirrhosis was diagnosed on the basis of medical docu- 
mentation, biochemical tests, USG, CT, and MRI examination 
of the abdominal cavity. A liver biopsy was performed in 16 
patients. The stage of hepatic insufficiency was assessed us­
ing the Child-Pugh scale. The etiology of liver cirrhosis in the 
patient group was viral hepatitis B or C.
The following examinations were performed: medical history in- 
quiry, biochemical tests, and neurological and neuropsycholog­
ical tests. According to recommendations for routine neuropsy­
chological assessment [6,7], the following tests were used: the 
Digit Symbol Test (DST) [25], the Block Design Test (BDT) [25], 
and TMT [22,26]. The battery also includes: the Letter Fluency 
(LF) and the Semantic Fluency (SF) tests [22,26], the Auditory 
Verbal Learning Test (AVLT) [27], and the computerized version 
of the Mental Rotation Test (MRT) [28]. The MRT has not been 
used until now in MHE diagnosis. These tests measure atten- 
tion and psychomotor speed (DST, TMT A), executive functions 
(TMT B, LF), language (SF), episodic memory (AVLT), and visuo- 
spatial abilities with the influence of constructional abilities 
(BDT) and without them (MRT). It was assumed that MHE would 
be diagnosed when the subject scored 2 standard deviations 
(SD) below the mean of the control group in at least 2 tests.
Statistical analysis
Due to violated normality assumption in the data distributions, 
results were analyzed using the non-parametric Mann-Whitney 
U test (neuropsychological data) and Kruskal-Wallis test (liver 
cirrhosis etiology). To avoid type-I errors (false positive) related 
to multiple comparisons, p-levels obtained in single analysis 
were corrected using the FDR (false discovery rate) procedure. 
The co-variation between the biochemical and neuropsycho- 
logical data was analyzed with Spearman’s rho correlation.
Results
Demographic data in both groups are shown in Table 1. The 
MMSE scores did not reveal significant differences between





Age (SD) 40.91 (10.87) 40 (13.21)
Men (N%) 29 (50.88%) 23 (47.92%)
Education (N%)
<12 years of education 14 (24.56%) 8 (16.67%)
12 years of education 22 (38.60%) 18 (37.50%)
16 years of education 21 (36.84%) 22 (45.83%)
SD -  standard deviation; N -  sample size.





Platelets, pL 193.25 225.96
0.15
[norm: 125-340] (80.63) (59.58)
INR 1.07 1.01
0.04*
[norm: 0.91-1.2] (0.18) (0.08)
AST, U/L 58.95 25.44
<0.01*
[norm 10-40] (44.5) (12.81)
ALT, U/L 95.69 32.52 <0.01*
[norm: 10-41] (109.64) (23.23)
AP, U/L 232.73 147.38
<0.01*
[norm :91-258] (158.15) (82.29)
GGTP, U/L 179.45 37.44
<0.01*
[norm: 5-61] (234.25) (45.96)
Bilirubin, pmol/L 17.68 12.69 0.04*[norm: 0-17.1] (14.12) (6.84)
Albumin, g/L 45.36 47.10
0.12[norm: 35-50] (4.43) (4.28)
Ammonia, pmol/L 40.31 22.17
<0.01*






SD -  standard deviation. Asterisks indicate a significant 
difference between groups. N -  sample size; p -  significance 
level (Mann-Whitney U-test).
the patient and the control group (29.03; SD 1.38 vs. 29.80; 
SD 0.50). Therefore, the cognitive abilities measured by this 
test were equal in both groups.
Significant differences between the groups were found in com- 
plete blood count for AST, ALT, AP, GGTP, ammonia (p<0.01), 
INR, and bilirubin level (p<0.05). In the clinical group, a de- 
creased number of thrombocytes and a decreased level of al­
bumin were observed, but did not reach statistical significance. 
The results of the biochemical tests are shown in Table 2.
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Table 3. Results of neuropsychological tests (SD values in brackets).
Clinical group Control group p FDR-pN=57 N=48
AVLT 1 correct responses 6.39 (1.61) 6.96 (1.97) 0.13 0.19
AVLT 2 correct responses 9.09 (2.33) 9.44 (2.41) 0.72 0.99
AVLT 3 correct responses 10.58 (2.34) 11.33 (2.09) 0.15 0.19
AVLT 4 correct responses 11.26 (2.18) 12.00 (2.18) 0.06 0.17
AVLT 5 correct responses 11.77 (2.36) 12.54 (2.12) 0.06 0.17
AVLT 1-5 total correct responses 49.09 (9.31) 52.27 (9.42) 0.11 0.18
AVLT 1-5 total perseverations 2.63 (3.41) 2.77 (2.52) 0.27 0.29
AVLT 1-5 total intrusions 1.07 (2.54) 0.35 (0.89) 0.26 0.28
AVLT delayed recall - correct responses 10.87 (2.8) 11.83 (2.82) 0.09 0.18
AVLT delayed recall - intrusions 0.59 (0.81) 0.23 (0.59) 0.006 0.05*
DST points 50.26 (12.42) 54.08 (11.71) 0.18 0.21
TMT A time (s) 29.07 (12) 28.13 (8.93) 0.81 0.99
TMT A errors 0.16 (0.37) 0.15 (0.41) 0.67 0.99
TMT B time (s) 73.96 (41.02) 70.60 (39.52) 0.99 0.99
TMT B errors 0.33 (1.11) 0.50 (0.88) 0.12 0.19
LF correct responses 16.21 (5.36) 17.06 (4.77) 0.32 0.38
SF correct responses 22.79 (5.83) 22.65 (6.77) 0.68 0.99
BDT points 30.89 (8.27) 32.63 (8.29) 0.31 0.38
MRT correct responses 23.84 (4.01) 23.81 (4.86) 0.77 0.99
MRT errors 7.98 (3.92) 8.85 (5.82) 0.79 0.99
SD -  standard deviation; AVLT -  Auditory Verbal Learning Test; DST -  Digit Symbol Test; TMT -  Trail Making Test; LF -  letter fluency; 
SF -  Semantic Fluency; BDT -  Block Design Test; MRT -  Mental Rotation Test. Asterisks indicate significant differences between 
groups. N -  sample size; p -  significance level (Mann-Whitney U-test); FDR-p -  FDR corrected significance level.
Neither biochemical nor neuropsychological differences were 
observed in relation to the various etiologies of liver cirrhosis 
in the clinical group. No correlations were found between bio­
chemical and neuropsychological scores in any of the groups.
Neuropsychological test scores are shown in Table 3. As can be 
seen, more intrusions were found in the clinical group (0.59; 
SD 0.81) than in the control group (0.23; SD 0.59) in the AVLT 
delayed free recall trial (p<0.01).
The criterion of deviating more than 2 SD on at least 2 tests 
was fulfilled in 7 (12.3%) liver cirrhosis patients. However, 
more patients revealed such deviation on 1 of the tests only. 
This does not satisfy the MHE criteria, although it shows 
some selective cognitive impairments. The data are present- 
ed in Table 4.
Discussion
The only statistical difference between the clinical and the 
control group was found in the intrusions level in the AVLT 
delayed free recall. Intrusions can be interpreted as difficul- 
ty in distinguishing whether information currently present in 
the mind is a kind of recollection related to the task or an as- 
sociation not related to the task itself, which is called source 
monitoring [26]. In the cognitive model of intrusions it is as- 
sumed that they can result from natural processes organizing 
encoding and retrieval [29]. According to this model, all infor­
mation that is temporarily stored in the short-term memo­
ry (STM) activates semantically or phonetically related infor­
mation in the long-term memory (LTM). During the encoding 
phase, relevant task-related information can activate content 
from the LTM, which is not directly related to the task, and
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Table 4. Psychometric tests in which single subjects scored 
below 2SD from the mean.
SD -  standard deviation; AVLT -  Auditory Verbal Learning Test;
LF -  Letter Fluency; TMT A -  Trail Making Test A; TMT B -  Trail 
Making Test B; WAIS-R -  Wechsler Adult Intelligence Scale- 
Revised; DST -  Digit Symbol Test; BDT -  Block Design Test;
N -  sample size; p -  significance level (chi-square).
both can be encoded together. Retrieval in this model is de- 
scribed as activation of information in the LTM related to the 
retrieval cue. One recalled piece of information helps in the 
recall of another (e.g., one word from the list helps in the re- 
call of the next word). Even when the information has been 
encoded properly, the retrieved information can activate con- 
tent in LTM that is non-related to the task. Clinical data show 
that basic functions such as organizing and controlling infor­
mation processing in memory can be assigned to the execu- 
tive functions cognitive domain.
A high amount of intrusions in tests based on learning a list 
of words (such as AVLT) can be observed in frontal lesions [26] 
and in dementia, including Alzheimer’s disease (AD) [30]. AD 
impairs episodic memory at its early stages; this is the main 
reason for decreased AVLT performance. However, the rela- 
tionship between intrusions in free recall trials and efficiency 
of the frontal lobes in AD has been proved [31]. An increase 
of intrusions was also found, to a lesser extent, in a group of 
schizophrenia patients with executive function disorders com- 
pared to those with schizophrenia but without executive im- 
pairments [32]. Similarly, the same effect was found in children 
with either Tourette syndrome or ADHD compared to a con­
trol group, even when executive functions tests did not show 
any changes [33]. Similar results were obtained in our study, 
where the measures of executive functions (TMT B, fluency 
tests) did not show an apparent decrease in performance. This 
suggests that the number of intrusions in AVLT is a very sensi- 
tive indicator in both mild and severe cognitive disorders and
is related to other kinds of executive functions than those ex- 
amined with the TMT B or fluency tests.
No significant differences were found in AVLT measures of 
short-term memory span (the first trial), learning process 
(sum of tests 1-5), or general index of encoding and retrieval 
(correct answers in delayed free recall trial), which suggests 
that the 2 groups do not differ in episodic memory, although 
some near-significant subtle differences were observed. Ortiz 
et al. [34] described episodic memory impairment measured 
with AVLT in MHE patients with subsequent improvement af- 
ter liver transplantation. However, the number of errors was 
not considered in this study. It can be assumed that a larger 
sample would make our near-significant AVLT effects stron- 
ger, which is in line with the suggestion of specific memory 
impairments in MHE.
The tests in which the cirrhosis patients scored 2 SD below the 
mean were most often related to executive functions (TMT B 
and LF), to psychomotor speed (TMT A and DST), and to mem­
ory (AVLT). Executive dysfunction and bradyphrenia are symp­
toms of a subcortical profile of cognitive impairment, which 
is sometimes described in MHE patients [35]. However, there 
were only a few patients diagnosed with MHE according to the 
criteria used in our study. This does not allow us to reach con- 
clusions about the specific profile of cognitive impairments. 
Recommendations for MHE diagnosis suggesting the use of 
neuropsychological tests (e.g., BDT, DST, or TMT) or screen­
ing batteries (e.g., PHES or RBANS) are designed for quanti- 
tative assessment. In such a case, the number of failed tests 
is taken into account, but not their specific kind. This is not 
theoretically satisfying, but in light of the obtained results, 
no further directions for clinical practice can be provided un- 
less future research reveals more reliable data on the cogni- 
tive profile of MHE.
Conclusions
Among the many neuropsychological tests used in this study, 
only one showed significant differences in performance. It was 
found that patients with liver cirrhosis have a tendency to 
commit significantly more errors of intrusions in the AVLT test 
during the delayed free recall trial, but they perform relatively 
well in other kinds of tasks. Although no MHE-specific profile 
of cognitive deficits could be identified, our findings suggest 
that cirrhosis patients have a tendency to commit more mem­
ory errors. This was interpreted as a possible effect of subtle 
impairments of executive function.
Conflict of interests





AVLT 1 correct responses 1 (1.75%) 0 (0.0%) 0.36
AVLT 5 correct responses 3 (5.26%) 3 (6.25%) -
AVLT 7 delayed recall 
-  correct responses
4 (7.02%) 2 (4.17%) 0.49
LF correct responses 4 (7.02%) 2 (4.17%) 0.53
TMT A time (s) 4 (7.02%) 2 (4.17%) 0.53
TMT B time (s) 5 (8.77%) 3 (6.25%) 0.63
DST points 4 (7.02%) 1 (2.08%) 0.24
BDT points 3 (5.26%) 2 (4.17%) 0.79
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